The present invention relates to formula (I) Wherein the radicals R 1 to R 4 , R 7 , A, D, E, F, V, W, X, Y, n, r and q are defined in claim 1 Compounds, their use as inhibitors of MDM2-p53 interactions, pharmaceutical compositions containing such compounds, their use as medicaments, in particular as medicaments for the treatment and / or prophylaxis of cancer diseases, and Including intermediates.本発明は式 (I)(式中、基R1~R4、R7、A、D、E、F、V、W、X、Y、n、r及びqは請求項1に定義される)の化合物、MDM2-p53相互作用の阻害薬としてのそれらの使用、この種の化合物を含む医薬組成物、薬物、特に癌疾患の治療及び/又は予防のための薬剤としてのそれらの使用、並びに合成中間体を含む。